Stocks/ACT

ACT three-lens brief

Evidence-based stock research on ACT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

52-week rangeas of 07:00 ET
$36.77$46.16$50.56

Performance

1W
-4.3%
1M
+2.8%
3M
-7.3%
6M
—
YTD
—
1Y
—
3Y
—
5Y
—
ACT · Nightly brief
Watch

P/E of 9.6 — trading at a value multiple.

  • P/E of 9.6 — trading at a value multiple.
  • Reported earnings on 2026-11-04.
  • Ex-dividend date 2026-11-25.

ACT closed at $46.16 (-0.09%) as of 2026-11-12. Market cap: $6.21B. P/E (trailing) 9.6. Price is below the 50-day MA and above the 200-day MA. Positives: p/E of 9.6 — trading at a value multiple.. Last quarter: Revenue $312.85M, net income $158.91M, free cash flow $529.59M.

Market ✓· Fundamentals ✓· 2 events
Informational only · Not investment advice
Three-lens method

Why three lenses on ACT, not one.

A single reasoning model has blind spots it doesn’t know about. We examine ACT across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://www.clearpathinvest.app/embed/ACT"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath ACT brief"></iframe>